Literature DB >> 21432263

Diagnosis and prevention of diseases induced by isocyanate.

Kazuko Nakashima1, Tatsuya Takeshita, Kanehisa Morimoto.   

Abstract

Isocyanates are among the most frequent causes of occupational asthma in industrialized countries. Early diagnosis of diisocyanate asthma followed by prompt termination of chemical exposure can prevent chronic morbidity due to persistent asthma. Chronic exposure to isocyanates also induces hypersensitivity pneumonitis (HP). The accurate diagnosis of diisocynate asthma requires a systematic approach that combines information obtained from the occupational history, immunologic tests and physiologic studies. The prevention of health problems from toluene diisocyanate (TDI), 4,4'-methylenediphenyl diisocyanate (MDI) and 1,6'-hexamethylene diisocyanate (HDI) is essential for all those handling the chemicals. Regulatory exposure limits should be observed. However, wheezing, coughing or even asthmatic attacks may occur after exposure much below the regulatory exposure limits especially in sensitive individuals. Preventing or minimizing exposure is of prime importance and should be supported by the installation of engineering controls, by education of the workforce, by regular monitoring of the workplace exposure and by medical surveillance. To prevent such asthma it is suggested that workers should be tested airway sensitivity and should avoid working in areas that have dust containing specific-IgE. Such tests must be periodically performed after working. Symptoms induced by isocyanate need earlier discover and early isolation of the associated individuals.

Entities:  

Keywords:  diagnosis; diisocyanate; isocyanates; prevention; review

Year:  2002        PMID: 21432263      PMCID: PMC2723398          DOI: 10.1007/BF02897329

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  54 in total

1.  Hexamethylene diisocyanate induction of transient airway hyperresponsiveness in guinea pigs.

Authors:  W Marek; T Mensing; F Riedel; N Viso; B Marczynski; X Baur
Journal:  Respiration       Date:  1997       Impact factor: 3.580

2.  Canadian Thoracic Society guidelines for occupational asthma.

Authors:  S M Tarlo; L P Boulet; A Cartier; D Cockcroft; J Côtè; F E Hargreave; L Holness; G Liss; J L Malo; M Chan-Yeung
Journal:  Can Respir J       Date:  1998 Jul-Aug       Impact factor: 2.409

3.  Nasal response in subjects undergoing challenges by inhaling occupational agents causing asthma through the nose and mouth.

Authors:  M Desrosiers; B Nguyen; H Ghezzo; C Leblanc; J L Malo
Journal:  Allergy       Date:  1998-09       Impact factor: 13.146

Review 4.  Isocyanates and health--a review.

Authors:  A B Zwi
Journal:  S Afr Med J       Date:  1985-02-09

Review 5.  Isocyanate-induced pulmonary diseases: a current perspective.

Authors:  I L Bernstein
Journal:  J Allergy Clin Immunol       Date:  1982-07       Impact factor: 10.793

Review 6.  Overview of diisocyanate occupational asthma.

Authors:  J A Bernstein
Journal:  Toxicology       Date:  1996-07-17       Impact factor: 4.221

Review 7.  Current diagnostic methods for diisocyanate induced occupational asthma.

Authors:  D I Bernstein; A Jolly
Journal:  Am J Ind Med       Date:  1999-10       Impact factor: 2.214

8.  [A case of hypersensitivity pneumonitis induced by toluene diisocyanate presenting with transient bronchoconstriction].

Authors:  T Bando; Y Noda; J Hirose; G Ohta; K Shibata; M Fujimura; T Matsuda
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1993-10

9.  Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression.

Authors:  D Robinson; Q Hamid; S Ying; A Bentley; B Assoufi; S Durham; A B Kay
Journal:  Am Rev Respir Dis       Date:  1993-08

10.  [A case of hypersensitivity pneumonitis due to isocyanate exposure showing progression even two months after removal of the antigen].

Authors:  T Akimoto; N Tamura; K Uchida; T Dambara; T Nukiwa; S Kira
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1992-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.